Evaluation of dermatological safety of skin bleaching products by single open application test on healthy female subjects belonging to the age group 18-50 years. - NI

Dabur India Limited0 sites24 target enrollmentStarted: TBDLast updated: November 24, 2021

Trial Snapshot

No summary available.

•Healthy female subjects in age group 18 - 50 years (both the ages inclusive).
•Subjects with Fitzpatrick skin type III to V.
•Subjects who are not allergic to bleaching products as per medical history.
•Subjects willing to give a voluntary written informed consent.
•Subject having not participated in a similar investigation in the past two weeks.
•Subjects willing to come for regular follow up visits.
•Subjects ready to follow instructions during the study period.

•Infection, allergy on the tested area.
•Skin allergy, antecedents or atopic subjects.
•Athletes and subjects with history of excessive sweating.
•Cutaneous disease which may influence the study result.
•Subjects on oral corticosteroid >10mg/day.
•Subjects participating in any other cosmetic or therapeutic study.
•Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Sponsor